A client with advanced-stage Alzheimer's disease is seen by a health care provider who prescribes a newer drug that is not a cholinesterase inhibitor. This drug is a N-methyl-D-asparate (NMDA) receptor antagonist. This drug is better known as:
Is one of the most commonly used cough suppressants in the world and is known to be an NMDA receptor antagonist and its function is linked to that of the array of negative symptoms and are classified as dissociative drugs
